Zobrazeno 1 - 10
of 12
pro vyhledávání: '"George E Hucks"'
Autor:
Timothy J. Voorhees, Anne W. Beaven, Christopher Dittus, George E Hucks, J. Kaitlin Morrison, Catherine Joyce Arago Cheng, Tammy Cavallo, Steven I. Park, Gianpietro Dotti, Jonathan S. Serody, Barbara Savoldo, Natalie S. Grover
Publikováno v:
Blood. 140:12723-12724
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b6dc7c4f408315693b2eb3885d6ed7b5
https://doi.org/10.1182/blood-2022-156660
https://doi.org/10.1182/blood-2022-156660
Autor:
Jonathan S. Serody, Timothy J Voorhees, Natalie S Grover, Anne W. Beaven, Amir H. Khandani, Jennifer S. Smith, Catherine Cheng, J. Kaitlin Morrison, Anastasia Ivanova, George E Hucks, Beibo Zhao, Thomas B. Shea, Barbara Savoldo, Jorge Oldan, Gianpietro Dotti, Steven I. Park, Christopher Dittus
Publikováno v:
Blood advances. 6(4)
Our group has recently demonstrated that chimeric antigen receptor T-cell therapy targeting the CD30 antigen (CD30.CAR-T) is highly effective in patients with relapsed and refractory (r/r) classical Hodgkin lymphoma (cHL). Despite high rates of clini
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2a11227a1686d5b02a171c6c0b220ea
https://pubmed.ncbi.nlm.nih.gov/34666347
https://pubmed.ncbi.nlm.nih.gov/34666347
Autor:
Michael Winstead, Thomas C. Shea, George E Hucks, J. Kaitlin Morrison, Marcie L. Riches, Anne W. Beaven, Natalie S Grover, Caroline Babinec, Gianpietro Dotti, Catherine Cheng, Arpita Patel, Barbara Savoldo, Jonathan S. Serody, Kimberly A. Kasow, Cammie Moore Presler
Publikováno v:
Blood. 138:2829-2829
Background: Chimeric antigen receptor (CAR)-T cell therapy targeting the CD19 antigen has been effective in treating B-cell acute lymphoblastic leukemia. As CAR-T cells targeting new antigens are being explored for the treatment of other cancers in a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f9c3664747e638d2b64bf648b4173a4d
https://doi.org/10.1182/blood-2021-153968
https://doi.org/10.1182/blood-2021-153968
Autor:
Philip A. Roehrs, Katarzyna Jamieson, J. Kaitlin Morrison, Gianpietro Dotti, Barbara Savoldo, Natalie S Grover, George E Hucks, Paul M. Armistead, Spencer Laing, Matthew C. Foster, Faith Brianne Buchanan, Jonathan S. Serody, Catherine Cheng
Publikováno v:
Blood. 136:36-37
Introduction: CAR-T cells targeting the CD19 antigen are approved to treat children and young adults with relapsed and refractory B-cell ALL, in whom response rates are >80%. Acute toxicities, including cytokine release syndrome (CRS) and immune effe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0e5d1883c62aed5906cbacd4b99ec18e
https://doi.org/10.1182/blood-2020-139051
https://doi.org/10.1182/blood-2020-139051
Autor:
George E Hucks, Susan R. Rheingold
Publikováno v:
Blood Cancer Journal
Blood Cancer Journal, Vol 9, Iss 2, Pp 1-9 (2019)
Blood Cancer Journal, Vol 9, Iss 2, Pp 1-9 (2019)
Outcomes of pediatric and young adult patients diagnosed with acute lymphoblastic leukemia (ALL) have improved significantly in the past few decades. Treatment advances have provided 5-year survival rates ranging from 78 to 91% depending on the age a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53a3bd8c9033cfa681e2900c172a9457
https://pubmed.ncbi.nlm.nih.gov/30670684
https://pubmed.ncbi.nlm.nih.gov/30670684
Autor:
Cammie Moore Presler, Arpita Patel, Joshua J. Bies, Timothy J. Vece, Kimberly A. Kasow, Michael Winstead, George E Hucks
Publikováno v:
Biology of Blood and Marrow Transplantation. 25:S316
Intro/Objectives Warts, hypogammaglobulinemia, infections, myelokathexis (WHIM) syndrome is a rare primary immunodeficiency defined by its symptoms and CXC chemokine receptor 4 (CXCR4) gene mutation. This leads to myelokathexis in which mature neutro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ef52f8524395dac882ead0329585b323
https://doi.org/10.1016/j.bbmt.2018.12.646
https://doi.org/10.1016/j.bbmt.2018.12.646
Autor:
Erika Mora, Ed Rothman, F. Jacob Seagull, George E Hucks, Schuyler Halverson, Kelly Walkovich, Kaleena Johnson, Michele M. Nypaver, Christopher A. Benner, John G. Younger, Emily L. Mueller
Publikováno v:
Pediatric emergency care. 34(5)
OBJECTIVES Febrile neutropenic pediatric patients are at heightened risk for serious bacterial infections, and rapid antibiotic administration (in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::578d1643887d62e9f442bb585f77df05
https://pubmed.ncbi.nlm.nih.gov/27749799
https://pubmed.ncbi.nlm.nih.gov/27749799
Autor:
Susan R. Rheingold, John Scholler, Katherine T. Marcucci, Jennifer Brogdon, Noelle V. Frey, George E Hucks, Simon F. Lacey, David L. Porter, Richard Aplenc, Pamela A. Shaw, Mala K. Talekar, Shannon L. Maude, Claire White, Colleen Callahan, Carl H. June, J. Joseph Melenhorst, Regina M. Young, Anne Chew, David T. Teachey, Stephan A. Grupp, David M. Barrett, Bruce L. Levine, Diane Baniewicz
Publikováno v:
Cytotherapy. 19:S9-S10
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6e9d9af1b0a124f3274ad2d06dbf441e
https://doi.org/10.1016/j.jcyt.2017.02.011
https://doi.org/10.1016/j.jcyt.2017.02.011
Autor:
Beth McBride, David T. Teachey, Stephan A. Grupp, Farzana Nazimuddin, Colleen Callahan, Simon F. Lacey, Diane Baniewicz, Vanessa E. Gonzalez, Amanda M. Li, Carl H. June, Alix E. Seif, Christina Fasano, George E Hucks, David L. Porter, Amanda M. DiNofia, Shannon L. Maude
Publikováno v:
Blood. 132:556-556
Abstract CAR T cell therapy in relapsed B-ALL can result in complete response (CR) rates of 80-90%, but relapse-free survival declines to 60% within the first 12-months due to both CD19-positive and negative relapses. CD19-positive relapses that occu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f01caeec038a7e98a41a1026cbbb3d4e
https://doi.org/10.1182/blood-2018-99-112572
https://doi.org/10.1182/blood-2018-99-112572
Autor:
Laura S Motley, J. Joseph Melenhorst, Colleen Callahan, David M. Barrett, George E Hucks, Susan R. Rheingold, Simon F. Lacey, Bruce L. Levine, David T. Teachey, Stephan A. Grupp, Diane Baniewicz, Mala K. Talekar, Claire White, Carl H. June, Shannon L. Maude
Publikováno v:
Journal of Clinical Oncology. 35:10507-10507
10507 Background: Anti-CD19 CAR-T cell therapies have shown high efficacy in inducing durable marrow responses in patients with relapsed/refractory CD19+ ALL. We now report on outcome of 10 patients with extramedullary (EM) involvement of ALL treated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2ca57a68db7b36faa7f17b0a0d4fefa8
https://doi.org/10.1200/jco.2017.35.15_suppl.10507
https://doi.org/10.1200/jco.2017.35.15_suppl.10507